DOV 22047

Drug Profile

DOV 22047

Alternative Names: DOV 22,047

Latest Information Update: 17 Nov 2007

Price : $50

At a glance

  • Originator DOV Pharmaceutical
  • Class
  • Mechanism of Action GABA A receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Anxiety disorders

Most Recent Events

  • 17 Nov 2007 Discontinued - Preclinical for Anxiety disorders in USA (unspecified route)
  • 27 Mar 2006 No development reported - Preclinical for Anxiety disorders in USA (unspecified route)
  • 11 Feb 2004 This compound is still in active development
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top